4th Quarter - Report
BURRELL INTERNATIONAL GROUP LLC for TONIX PHARMACEUTICALS HOLDING CORP.
Income
$40,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
LHHS Appropriation R&D Funding, Pandemic Preparedness Funding for Next Generation Products; FY26 Defense Appropriation for broad-spectrum antivirals, FY26 LHHS for Long COVID and cocaine overdose funding; Alternative to Pain Act and Chronic Pain coverage
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBORAH LYNN BURRELL | — |
| KRISTIN STEVENS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.